Earn Up to 2 hours of CME!

Double Tree Hotel by Hilton, San Juan PR

Pre-Registration is required.

Free of Charge

Program Description

This CME conference is designed to provide healthcare professionals with an in-depth understanding of the latest advances and emerging therapies in secondary stroke prevention. The program will explore the limitations of current antithrombotic strategies, particularly in relation to bleeding risks, and introduce factor Xl as a promising novel target for antithrombotic therapy. Through expert-led sessions and interactive discussions, participants will gain insights into the mechanisms of action and clinical profiles of FXI inhibitors, and review evolving clinical data supporting their use in various patient populations, including those with atrial fibrillation, acute coronary syndrome, and venous thromboembolism. Attendees will leave equipped with practical knowledge to confidently integrate new therapies into stroke management, ultimately aiming to enhance patient outcomes and address unmet needs in stroke prevention.